First Tracks Biotherapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TRAX Nasdaq 2836 www.firsttracksbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update - Aug 12th, 2026 2:15 pm
TRAX Stock Hits All-Time High — What's Driving The Super Rally? - Jul 10th, 2026 10:14 am
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - May 21st, 2026 2:15 pm
How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets - May 15th, 2026 8:18 am
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update - May 14th, 2026 2:15 pm
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update - May 12th, 2026 2:15 pm
Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal Outcome - May 10th, 2026 7:10 pm
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026? - May 10th, 2026 5:13 pm